Berberine attenuates non-alcoholic steatohepatitis by regulating chemerin/CMKLR1 signalling pathway and Treg/Th17 ratio

Protective effects of berberine hydrochloride on DSS-induced ulcerative colitis in rats

Pei‐Qing Gu, Hong Shen · International Immunopharmacology · 2019 · 259 citations

Life Sciences, Immunology, Pharmacology +16

Efficacy of Berberine in Patients with Non-Alcoholic Fatty Liver Disease

Hongmei Yan, Mingfeng Xia, Yan Wang et al. · PLoS ONE · 2015 · 228 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +17

Disruption of the Chemokine-Like Receptor-1 (CMKLR1) Gene Is Associated with Reduced Adiposity and Glucose Intolerance

Matthew C. Ernst, Ian D. Haidl, Luis Zúñiga et al. · Endocrinology · 2011 · 171 citations · Full text

Life Sciences, Immunology, Physiology +17

Lipid profiling of the therapeutic effects of berberine in patients with nonalcoholic fatty liver disease

Xinxia Chang, Zhe Wang, Jinlan Zhang et al. · Journal of Translational Medicine · 2016 · 96 citations · Full text

Life Sciences, Biochemistry, Pharmacology +17

Chemerin is highly expressed in hepatocytes and is induced in non-alcoholic steatohepatitis liver

Sabrina Krautbauer, Josef Wanninger, Kristina Eisinger et al. · Experimental and Molecular Pathology · 2013 · 93 citations

Medicine, Biochemistry, Pathobiology +11